Centre for Health Solutions – Kenya (CHS) is honoured to receive the USAID award to partner with the National Tuberculosis, Leprosy and Lung Disease Program (NTLD-Program) in reducing the burden of TB in Kenya. This funding is made possible by the American people through the United States Agency for International Development (USAID). The purpose of this award is to reduce the incidence and number of deaths due to TB in Kenya, in line with the global End TB goal of “A world free of TB, by ensuring Zero TB deaths, Zero TB disease and Zero TB Suffering.”
The Tuberculosis Accelerated Response and Care II (TB ARC II) program aims to improve TB case finding by increasing access to high quality, patient-centered TB, DR-TB and TB/HIV services, preventing TB transmission and disease progression through strengthening TB service delivery platforms, and finally accelerating research and innovation with the ultimate goal of decreasing incidence, and TB-related morbidity and mortality in line with the 90-95-0 targets to End the TB epidemic.
